Review Article Autoimmune encephalitis - Recent Guidelines for Diagnosis and Management: Autoimmune encephalitis - Recent Guidelines for Diagnosis and Management

Rajendra S Jain

doi:10.15713/ins.bhj.79

Authors

Rajendra S Jain MD, DM, FRCP (London), FRCP (Edin), FIAN, Senior Professor & Head Neurology Unit University S.M.S. Medical College, Jaipur

DOI:

https://doi.org/10.15713/ins.bhj.79

Abstract

Autoimmune encephalitis (AE) is a group of acute to subacute onset, rapidly progressive, non-infectious, immune-mediated, inflammatory disorders of the brain parenchyma often affecting the cortical or deep grey matter with or without involving the white matter, meninges or spinal cord.^1-4 An estimated prevalence rate for AE is 13.7/100 000, so possibly as common as infectious encephalitis.⁵ ‘Autoimmune neurology’ is coming up with the advent of newer antibodies and associated syndromes.⁶ Identifying these disorders is rewarding in view of favourable response to immunotherapy compared to infectious encephalitis with limited therapeutic options. Clinicians need to suspect AE clinically first to plan investigations and early treatment.¹ Long-term management depends on antibody identified. Recent guidelines for diagnosis and management of AE are discussed here.

References

Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016;15:391–404.

Dalmau J, Graus F. Antibody-Mediated encephalitis. N Engl J Med 2018;378:840–51.

Heine J, Prüss H, Bartsch T, et al. Imaging of autoimmune encephalitis--Relevance for clinical practice and hippocampal function. Neuroscience 2015;309:68–83.

Singh TD, Fugate JE, Rabinstein AA. The spectrum of acute encephalitis: causes, management, and predictors of outcome. Neurology 2015;84:359–66.

Dubey D, Pittock SJ, Kelly CR, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol 2018;83:166–77.

López-Chiriboga AS, Clardy SL. Emerging subspecialties in neurology: autoimmune neurology. Neurology 2017;89:e129–33.

Mittal MK, Rabinstein AA, Hocker SE, et al. Autoimmune encephalitis in the ICU: analysis of phenotypes, serologic findings, and outcomes. Neurocrit Care 2016;24:240–50.

López-Chiriboga AS, Flanagan EP. Diagnostic and therapeutic approach to autoimmune neurologic disorders. Semin Neurol 2018;38:392–402.

Kumar N, Abboud H. Iatrogenic CNS demyelination in the era of modern biologics. Mult Scler 2019;25:1079–85.

Lancaster E. Paraneoplastic disorders. Continuum 2017;23:1653–79.

Abboud H, Rossman I, Mealy MA, et al. Neuronal autoantibodies:

differentiating clinically relevant and clinically irrelevant results. J Neurol 2017;264:2284–92.

Fang B, McKeon A, Hinson SR, et al. Autoimmune glial fibrillary acidic protein Astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol 2016;73:1297–307.

Tobin WO, Guo Y, Krecke KN, et al. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 2017;140:2415–25.

Gaspard N, Foreman BP, Alvarez V, et al. New-Onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology 2015;85:1604–13.

Steriade C, Moosa ANV, Hantus S, et al. Electroclinical features of seizures associated with autoimmune encephalitis. Seizure 2018;60:198–204.

Solnes LB, Jones KM, Rowe SP, et al. Diagnostic Value of 18F-FDG PET/CT Versus MRI in the Setting of Antibody-Specific

Autoimmune Encephalitis. J Nucl Med 2017;58:1307–13.

Blinder T, Lewerenz J. Cerebrospinal fluid findings in patients with autoimmune Encephalitis-A systematic analysis. Front Neurol 2019;10:804.

Titulaer MJ, Soffietti R, Dalmau J, et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS Task force. Eur J Neurol 2011;18:19–e3.

Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014; 13: 167–77.

Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede LGI1 antibody limbic encephalitis. Ann Neurol 2011;69:892–900.

Maat P, de Beukelaar JW, Jansen C, et al. Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob

disease. Neurol Neuroimmunol Neuroinflamm 2015;2:e178.

Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA

receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157–65.

Titulaer MJ, Höftberger R, Iizuka T, et al. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014;75:411–28.

Nguyen MK, Rastogi A, Kurtz I. True hyponatremia secondary to intravenous immunoglobulin. Clin Exp Nephrol 2006;10:124–6.

Scheibe F, Prüss H, Mengel AM, et al. Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis. Neurology 2017;88:366–70.

Lee W-J, Lee S-T, Moon J, et al. Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study. Neurotherapeutics 2016;13:824–32.

Lim J-A, Lee S-T, Moon J, et al. New feasible treatment for refractory autoimmune encephalitis: low-dose interleukin-2. J Neuroimmunol 2016;299:107–11.

Nosadini M, Mohammad SS, Ramanathan S, et al. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother 2015;15:1391–419.

Keime-Guibert F, Graus F, Fleury A, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg

Psychiatry 2000;68:479–82.

Bloch MH, Hwang WC, Baehring JM, et al. Paraneoplastic limbic encephalitis: ovarian cancer presenting as an amnesic syndrome. Obstet Gynecol 2004;104:1174–7.

Shin Y-W, Lee S-T, Park K-I, et al. Treatment strategies for autoimmune encephalitis. Ther Adv Neurol Disord 2018;11:175628561772234.

Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 2008;7:327–40.

Khadilkar S, Soni G et al. Autoimmune encephalitis:an update. JAPI 2017;65:62-69.